At a glance
- Originator GEA Farmaceutisk Fabrik AS
- Class Antiasthmatics; Bronchodilators; Small molecules
- Mechanism of Action Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Airway obstruction
Most Recent Events
- 23 Feb 1999 GEA is now a subsidiary of Hexal
- 01 Apr 1998 Preclinical development for Airway obstruction in European Union (Unknown route)